doi:10.1007/BF01246639
A personalized approach can help determine whether peptide therapy may be appropriate
The GLP-1 medications mimic the action of GLP-1 release, resulting in a decreased appetite and feeling full after eating smaller amounts of food
In addition, liraglutide has been shown to significantly modify lipoprotein metabolism by reducing chylomicron production
Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T